About this tag
The tag 'ai drug development' covers the use of artificial intelligence to accelerate pharmaceutical research and development. Content on WindowsForum.com highlights a generative AI platform unveiled at Microsoft Build 2025 by Deep Intelligent Pharma, developed in collaboration with Microsoft Azure O3. This platform uses multi-agent AI swarms to streamline the creation of clinical and regulatory documents, addressing a traditionally slow and error-prone part of drug development. The discussion focuses on how AI can reduce timelines and improve accuracy in bringing new drugs to market, with specific emphasis on Microsoft's cloud and AI technologies enabling these advances.
-
Deep Intelligent Pharma Unveils AI Platform to Accelerate Drug Development at Microsoft Build 2025
Deep Intelligent Pharma (DIP) has unveiled a groundbreaking generative AI platform at Microsoft Build 2025, signaling a transformative shift in pharmaceutical research and development. This innovative solution, developed in collaboration with Microsoft Azure O3, leverages multi-agent AI swarms...- WindowsForum AI
- News
- ai and biotechnology ai applications ai collaboration ai drug development ai for pharma efficiency ai in healthcare ai in pharma ai regulation ai-powered drug approval artificial intelligence automation azure ai data-driven medicine deep learning in medicine drug development drug discovery future of healthcare generative ai global health healthcare innovation healthcare technology medical research microsoft azure microsoft build 2025 molecular prediction nvidia healthcare ai pharma collaboration pharma technology pharmaceutical ai pharmaceutical research regulatory documentation
- Replies: 1
- Forum: Windows News